MattenPlant Pte. Ltd., which is a Singapore-based expert in industrial and municipal water as well as wastewater treatment, has gone on to announce the launch of its Pharmaceutical Water for Injection – Cold WFI initiative, thereby introducing the first membrane technology-led Cold WFI system from Southeast Asia to the market.
Pharmaceutical manufacturers, engineering consultants as well as industry stakeholders are invited to stop by Matten’s Booth B2-D20 at Singapore International Water Week 2026 SIWW 2026 and discover more.
It is worth noting that for Matten, the launch of membrane technology-led Cold WFI system is a strategic decision to extend its scope into pharmaceutical water systems, leveraging its proven track record within the F&B and pharmaceutical industries, where hygienic system design as well as GMP compliance are fundamental requirements.
Pharmaceutical manufacturing investments continue to grow across Southeast Asia, with a need for a compliant water infrastructure that can be set up and maintained as well as improved closer to the point of use.
This initiative provides pharma manufacturers with access to locally assembled Cold WFI systems with regional engineering as well as service support.
A Critical Moment for Pharma Manufacturers
The company, through its Pharma initiative, happens to provide full pharmaceutical water systems, developed and engineered as well as built locally in Southeast Asia. The solution spans every stage of production, right from pre-treatment, high-purity water manufacturing, and distribution to post-use treatment, offering pharmaceutical manufacturers an entirely integrated solution backed locally.
The offering is built around cold WFI technology, which is an energy-efficient substitute when it comes to conventional thermal distillation that complies with globally accepted pharmacopoeial standards, including Ph. Eur. and USP.
Cold WFI systems do away with constant steam generation and hot water storage, cutting down on energy usage and operational costs, while simultaneously promoting sustainability goals with fewer carbon emissions.
Built for the Region and Supported by Local Expertise
Notably, Matten happens to be a qualified manufacturer who has direct presence in over 6 countries in Southeast Asia with production facilities within the region, offering pharmaceutical clients a dependable, on-the-ground partner all through the lifecycle of the system, right from design and commissioning to aftermarket servicing as well as upgrades. Local presence in Matten allows the company to react quickly to the changing needs of its customers.
According to MattenPlant CEO Victor Lim, Southeast Asia is a pharmerging hotspot. There is a surge of demand for regulated, efficient, locally supported water systems. Matten is well placed to be a reliable partner to pharmaceutical manufacturers in this part of the world, as they have the engineering knowledge and the manufacturing capacity, along with the regional presence.
Critical Infrastructure – Going Beyond Pharmaceuticals
Complementing pharmaceutical water solutions by Matten will be technologies that tackle water quality as well as sustainability issues across key infrastructure sectors.
This includes an online quick bacterial analyzer, which allows cooling tower operators to track Legionella risk in almost real time, which, by the way, is a growing concern for the data center industry, providing results in a matter of 20 minutes compared to traditional laboratory techniques, which can take several days.
Matten will offer solutions for resource utilization and reduction of emissions in sludge treatment as well as biogas optimization, N2O emission tracking and control, AI-driven polymer dosing as well as industrial water reuse systems, all of which are key to onsite water resilience as well as wastewater compliance.
It is worth noting that SIWW 2026 Water Expo is scheduled to be held at the Sands Expo & Convention Centre, Singapore, between 16 and 18 June 2026.